Medicine & Pharmaceuticals 

AMERICAN SKIN ASSOCIATION ANNOUNCES 2024 RESEARCH ACHIEVEMENT AWARDS & INAUGURAL FOUNDERS AWARD

American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting.

AMERICAN SKIN ASSOCIATION ANNOUNCES 2024 RESEARCH ACHIEVEMENT AWARDS & INAUGURAL FOUNDERS AWARD
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced late-breaking results from the pivotal phase of the admIRE pivotal clinical trial, plus...

Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting
Meditrina Announces 510(k) Clearance for Gen 2 Bipolar RF Hysteroscopy System and Aveta Glo Bipolar RF Device

Meditrina, a key leader in women's health medical devices, is thrilled to announce the FDA 510(k) clearance of its Gen 2 bipolar RF hysteroscopy system. This new system features bipolar radiofrequency technology, and a...

Meditrina Announces 510(k) Clearance for Gen 2 Bipolar RF Hysteroscopy System and Aveta Glo Bipolar RF Device
JASON S. GOLDSTEIN OF PARKER WAICHMAN LLP NAMED TO PLAINTIFFS' STEERING COMMITTEE IN NATIONAL GLUGAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION

Jason S. Goldstein, Senior Litigation Counsel in the Mass Torts Department for the national law firm Parker Waichman LLP, was appointed to the Plaintiffs' Steering Committee ("PSC") in the multi-district litigation...

JASON S. GOLDSTEIN OF PARKER WAICHMAN LLP NAMED TO PLAINTIFFS' STEERING COMMITTEE IN NATIONAL GLUGAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION
Adena Health midwife helps first-time parents through long, emotional journey

Jackson (OH) resident Kaley Lower vividly remembers the moment she first laid eyes on the daughter she never thought she would have.

Adena Health midwife helps first-time parents through long, emotional journey
Healthgrades Names Foothill Regional Medical Center a 2024 Patient Safety Excellence Award™ Recipient

Foothill Regional Medical Center has been recognized as a 2024 Patient Safety Excellence Award™ recipient by Healthgrades, the leading resource consumers use to find a hospital or doctor. This achievement, along with...

Healthgrades Names Foothill Regional Medical Center a 2024 Patient Safety Excellence Award™ Recipient
HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ EYE Ltd. Announce their Intention to Form a Distribution Partnership for the U.S Market

HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical) and MAGENTIQ-EYE Ltd., an AI medical device company, announced today their intention to form a partnership in the field of AI in Gastroenterology and to examine...

HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ EYE Ltd. Announce their Intention to Form a Distribution Partnership for the U.S Market
Real-World Evidence Leader in Inflammatory Bowel Disease, Target RWE, Announces Expanded Footprint with TARGET-GASTRO Registry of 30,000+ Patients At Digestive Disease Week

Real-world evidence leader, Target RWE, Real-world evidence leader Target RWE today announced a major expansion of its TARGET-GASTRO longitudinal registry, now 30,000+ patients strong, ahead of Digestive Disease Week (DDW)...

Real-World Evidence Leader in Inflammatory Bowel Disease, Target RWE, Announces Expanded Footprint with TARGET-GASTRO Registry of 30,000+ Patients At Digestive Disease Week
OMRON Healthcare's Presence at Heart Rhythm 2024 in the U.S.

OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society (HRS) in the U.S. At Heart Rhythm 2024, the Company will...

OMRON Healthcare's Presence at Heart Rhythm 2024 in the U.S.
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference

Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients with moderately to severely active Crohn's disease (CD) and ulcerative...

Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference
Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer

Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong,...

Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with...

FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Behavioral Health Leaders Network Rebrands as Brain Health Leaders Network

In honor of Mental Health Awareness Month, the Behavioral Health Leaders Network, a Kinetix Group network of excellence, announced it will rebrand as the Brain Health Leaders Network (BHLN).

Behavioral Health Leaders Network Rebrands as Brain Health Leaders Network
New Analysis on Hypertension Treatment to be Presented as Late-Breaking Research at National Kidney Foundation Spring Clinical Meetings

A new analysis of a study comparing two commonly used medications, chlorthalidone (CTD) and hydrochlorothiazide (HCTZ), is set to be presented as a late-breaking presentation at the annual 2024 National Kidney Foundation...

New Analysis on Hypertension Treatment to be Presented as Late-Breaking Research at National Kidney Foundation Spring Clinical Meetings
Olympus to Highlight EVIS X1 Endoscopy System and Colorectal Cancer Screening Solutions at Digestive Disease Week Annual Meeting

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today that it will highlight its EVIS X1™ endoscopy system and colorectal cancer screening...

Olympus to Highlight EVIS X1 Endoscopy System and Colorectal Cancer Screening Solutions at Digestive Disease Week Annual Meeting
Promising Findings on Kidney Function Preservation in IgA Nephropathy Patients at National Kidney Foundation Spring Clinical Meetings

A new study to shed light on the long-term nephroprotective potential of sparsentan compared to maximally titrated irbesartan (MT-IRB) in patients with IgA nephropathy (IgAN) is set to be presented as a late-breaking...

Promising Findings on Kidney Function Preservation in IgA Nephropathy Patients at National Kidney Foundation Spring Clinical Meetings
Cleaning Instructions for Medical Instruments Need an Overhaul

Infection preventionists are reaching out to policymakers for help with the regulatory process around the current convoluted medical device cleaning instructions, known as instructions for use or IFUs, with which they must...

Cleaning Instructions for Medical Instruments Need an Overhaul
Digestive Health Specialists Celebrates 25 Years of Excellence in Gastrointestinal Care in Northern Mississippi

Digestive Health Specialists (DHS) is proud to announce its 25th anniversary of providing patient centric digestive health services to the Northern Mississippi community. Since 1999, DHS has remained committed to...

Digestive Health Specialists Celebrates 25 Years of Excellence in Gastrointestinal Care in Northern Mississippi
Polaris Launches its 2023 Geared For Good Report

Polaris Inc. (NYSE: PII) today released its 2023 Geared For Good Report detailing Polaris' continued focus on operating in a responsible manner to support its employees, riders, communities where it operates and in the...

Polaris Launches its 2023 Geared For Good Report
International Paper Publishes 2023 Sustainability Report

International Paper released its?2023 Sustainability Report, which illustrates the progress made on our Vision 2030 goals and outlines our commitment to building a better future for people, the planet and our company.

International Paper Publishes 2023 Sustainability Report
Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets

Fresenius Medical Care (FME), the global leader in providing products and services for people with kidney diseases, is executing its strategic turnaround plan and is well on track to achieve its goals for 2024.

Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets
Mitsubishi Tanabe Pharma America Announces Presentations at XXIX World Congress on Parkinson's Disease and Related Disorders

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced two presentations on investigational ND0612 in Parkinson's disease (PD) will be shared at the International Association of Parkinsonism and Related...

Mitsubishi Tanabe Pharma America Announces Presentations at XXIX World Congress on Parkinson's Disease and Related Disorders
Kira Pharmaceuticals to Present Positive Long-term Results of KP104 in Phase 2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Study at the 2024 European Hematology Association (EHA) Hybrid Congress

Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that it will present positive long-term safety and efficacy results...

Kira Pharmaceuticals to Present Positive Long-term Results of KP104 in Phase 2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Study at the 2024 European Hematology Association (EHA) Hybrid Congress
Medivis Named Among Fast Company's Most Innovative Companies of 2024 for AR Surgical Technology

Medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, has been distinguished by Fast Company as one of the Most Innovative Companies of 2024,...

Medivis Named Among Fast Company's Most Innovative Companies of 2024 for AR Surgical Technology
Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline data from the HALOS Phase 1/2a open-label study of ION582 in Angelman syndrome. ION582 was safe and well tolerated in the study and showed...

Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
FX Shoulder Solutions, Inc. Receives FDA 510k Clearance for Full-Wedge Augmented Glenoid Baseplates

FX received 510k clearance for its full-wedge augmented glenoid baseplates.  The newly cleared baseplates bring 6 new options to the previously cleared portfolio.  There are now a combined total of 18 glenoid baseplate...

FX Shoulder Solutions, Inc. Receives FDA 510k Clearance for Full-Wedge Augmented Glenoid Baseplates
Sage Veterinary Imaging Welcomes Dr. Connor O'Brien

Sage Veterinary Imaging (SVI) has welcomed Connor O'Brien, DVM, to its new Spring imaging center where he will serve as imaging director.  The Sage Veterinary Imaging location in Spring opened in early May to serve...

Sage Veterinary Imaging Welcomes Dr. Connor O'Brien
University of California, Irvine, Verifies GATC Health's Ability to Predict Drug Efficacy, Safety and Off-target Effects

GATC Health Corp, a technology company advancing drug discovery and disease prediction using artificial intelligence (AI), has successfully completed two external AI platform validation tests in collaboration with a...

University of California, Irvine, Verifies GATC Health's Ability to Predict Drug Efficacy, Safety and Off-target Effects
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-2 and QWINT-4 phase 3 clinical trials evaluating once-weekly insulin efsitora alfa (efsitora) in adults with type 2 diabetes using...

With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
M42 receives Global Healthcare Accreditation Certification for Excellence in Medical Travel Patient Experience

M42 has achieved the Global Healthcare Accreditation (GHA) certification for Excellence in Medical Travel Patient Experience from the US for its pioneering approach. With an overall score of 91 per cent, this certification...

M42 receives Global Healthcare Accreditation Certification for Excellence in Medical Travel Patient Experience
Children's Health and UT Southwestern Receive $100 Million Donation from the Pogue Family for New $5 Billion Dallas Pediatric Campus

Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year....

Children's Health and UT Southwestern Receive $100 Million Donation from the Pogue Family for New $5 Billion Dallas Pediatric Campus
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024

Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at...

AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
Guideline Issued for People with Epilepsy Who May Become Pregnant

A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant. The guideline is published in the May 15, 2024, online...

Guideline Issued for People with Epilepsy Who May Become Pregnant
Endo to Announce First-Quarter 2024 Financial Results for Endo International plc

Endo, Inc. ("Endo" or the "Company"), a newly formed entity that recently acquired substantially all of the assets of Endo International plc ("EIP") as contemplated by EIP's plan of reorganization, will announce select...

Endo to Announce First-Quarter 2024 Financial Results for Endo International plc
Provisio Medical Announces First Commercial Clinical Cases Utilizing the Provisio™ SLT IVUS™ System

Provisio Medical, Inc., pioneers of Sonic Lumen Tomography™ (SLT) technology to provide real-time blood vessel measurements during vascular interventions, today announced the completion of the first commercial clinical...

Provisio Medical Announces First Commercial Clinical Cases Utilizing the Provisio™ SLT IVUS™ System
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended March 31, 2024.

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
Unlocking the Power of Pharma Marketing Analytics: How Quantzig's Solutions Drive ROI

Unlock the full potential of your marketing initiatives with Quantzig's cutting-edge analytics solutions tailored for the pharmaceutical industry. Contact us to learn more and schedule a personalized consultation with...

Unlocking the Power of Pharma Marketing Analytics: How Quantzig's Solutions Drive ROI
NAHQ Strengthens Executive Leadership to Fuel Further Growth & Advance Quality & Safety in the Healthcare Profession

The National Association for Healthcare Quality® (NAHQ) announced today that it has made strategic appointments in strengthening its executive leadership team with the hiring of Jessica Juozapavich as chief financial and...

NAHQ Strengthens Executive Leadership to Fuel Further Growth & Advance Quality & Safety in the Healthcare Profession
Family Care Center Continues Middle Tennessee Growth with New Mt. Juliet Clinic

Family Care Center proudly announces the grand opening of its state-of-the-art mental health clinic, poised to transform mental wellness in the heart of Mt. Juliet. With a commitment to providing compassionate care and...

Family Care Center Continues Middle Tennessee Growth with New Mt. Juliet Clinic
Study Shows Exclusive Human Milk Diet Benefits Term Infants Post-Gastroschisis Repair; Data To Be Presented at ESPGHAN 2024 Meeting

Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products, announced today that data demonstrating the benefits of Prolacta's Exclusive Human Milk Diet (EHMD) for term...

Study Shows Exclusive Human Milk Diet Benefits Term Infants Post-Gastroschisis Repair; Data To Be Presented at ESPGHAN 2024 Meeting
National Survey: Parents share worries about their child's mental health and want resources to better understand and support their child

A recent national survey conducted by Action for Healthy Kids found that parents and caregivers of school-aged youth share worries about time spent on electronics, physical safety at school and their child's mental...

National Survey: Parents share worries about their child's mental health and want resources to better understand and support their child
Dr. Douglas Fauser of Somers Orthopaedic Surgery & Sports Medicine Group Conducts First Autologous Live Stem Cell Knee Injection at OSSC, Offering New Hope for Osteoarthritis Patients

Dr. Douglas J. Fauser, a prominent sports medicine and total joint replacement specialist of the Somers Orthopaedic Surgery & Sports Medicine Group, along with Dr. Michael Baroody, a Board-Certified Plastic Surgeon,...

Dr. Douglas Fauser of Somers Orthopaedic Surgery & Sports Medicine Group Conducts First Autologous Live Stem Cell Knee Injection at OSSC, Offering New Hope for Osteoarthritis Patients
Health Care Service Corporation Is Expanding in Texas

Health Care Service Corporation is advancing its strategy to expand into neighborhoods where it can benefit from the skilled workforce in those communities and drive economic growth. The company has leased a 132,000 sq ft...

Health Care Service Corporation Is Expanding in Texas
Fertility Specialists Network Announces Scientific Director, Dr. Sheela Ali

Fertility Specialists Network ("FSN"), a portfolio company of LongueVue Capital ("LVC") is pleased to announce the expansion of its leadership team with the addition of a Scientific Director, Dr. Sheela S. Ali, PhD, HCLD,...

Fertility Specialists Network Announces Scientific Director, Dr. Sheela Ali
Feeding America study shows the amount of money people facing hunger need to be food secure reaches highest level in 20 years

The extra amount of money that people facing hunger said they need to have enough food reached its highest point in the last 20 years, according to Feeding America's annual Map the Meal Gap study. People facing hunger...

Feeding America study shows the amount of money people facing hunger need to be food secure reaches highest level in 20 years
Olympus Highlighting COPD Treatment, AI-Driven Screening Process and EVIS X1 Bronchoscopes at American Thoracic Society Annual Meeting

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today that it will highlight its algorithm-powered emphysema screening program along with...

Olympus Highlighting COPD Treatment, AI-Driven Screening Process and EVIS X1 Bronchoscopes at American Thoracic Society Annual Meeting
PREVISE ANNOUNCES UPCOMING PRESENTATION AT DIGESTIVE DISEASE WEEK (DDW) 2024

Previse, maker of Esopredict, a clinically available test that analyzes the methylation of biomarkers to assess the risk of esophageal cancer developing in patients with Barrett's Esophagus (BE), announced today the...

PREVISE ANNOUNCES UPCOMING PRESENTATION AT DIGESTIVE DISEASE WEEK (DDW) 2024
SYNERGY HOMECARE INTRODUCES SPECIALIZED CARE PROGRAM FOR INDIVIDUALS LIVING WITH CANCER AND THEIR FAMILIES

SYNERGY® HomeCare, the nation's fastest growing home care franchise, an Entrepreneur 500 ranked enterprise and a Top 50 Franchise according to Franchise Business Review, today announced its latest specialized care...

SYNERGY HOMECARE INTRODUCES SPECIALIZED CARE PROGRAM FOR INDIVIDUALS LIVING WITH CANCER AND THEIR FAMILIES
EVOQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

EVOQ Bio, a wholly-owned subsidiary of EVOQ Nano, today announced the successful completion of a Pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the preclinical and...

EVOQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections
IFF Unveils Its Controlled Release Platform Featuring Its Innovation and Trailblazing Excipients

IFF (NYSE: IFF), a global leader in food and beverage, home and personal care and health, today announced a new controlled release platform for its portfolio of controlled release products including METHOCEL™, ETHOCEL™,...

IFF Unveils Its Controlled Release Platform Featuring Its Innovation and Trailblazing Excipients
Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the results from its second Phase III study of tradipitant in motion sickness, confirming the previously reported results of two efficacy studies...

Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness
Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)

Aspen Neuroscience, Inc., a California-based private biotechnology company developing personalized regenerative therapies, has received a CLIN2 grant award of $8 million from the California Institute for Regenerative...

Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)
McKinsey & Company Publishes 2023 Environmental, Social, and Governance (ESG) Report

McKinsey & Company today released its 2023 ESG Report, "Accelerating sustainable and inclusive growth for all." The report describes how McKinsey has partnered with its clients, colleagues, and communities to drive...

McKinsey & Company Publishes 2023 Environmental, Social, and Governance (ESG) Report
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer

Eli Lilly and Company (NYSE: LLY) today announced that Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, and a member of Lilly's Executive Committee, will...

Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of its first trimester preeclampsia screening test to be performed between 11 and 14 weeks gestation to...

Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
Landmark Population-Based Study Reveals the Prevalence of Vascular and Alzheimer's Dementias Disease Among American Indians

Huntington Medical Research Institutes (HMRI), a pioneer in scientific research dedicated to unraveling diseases of the heart and brain, gains new insights into dementia among American Indians for the first time through a...

Landmark Population-Based Study Reveals the Prevalence of Vascular and Alzheimer's Dementias Disease Among American Indians
Ionis to host 2024 virtual Annual Meeting of Stockholders

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2024 virtual Annual Meeting of Stockholders followed by a general corporate update on Thursday, June 6, 2024.

Ionis to host 2024 virtual Annual Meeting of Stockholders
Atraverse Medical Receives FDA Clearance for HOTWIRE™ Left Heart Access Device, Oversubscribes Seed Round with $12.5M Invested

Atraverse Medical, a San Diego-based medical device company, today announces the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel device that enables zero exchange left-heart access while also acting as...

Atraverse Medical Receives FDA Clearance for HOTWIRE™ Left Heart Access Device, Oversubscribes Seed Round with $12.5M Invested
Mental Health Inequities Cost the US More Than $477 Billion Today and Could Increase to $14 Trillion by 2040 if Unaddressed, According to Analysis by Deloitte and Meharry School of Global Health

SOURCE Deloitte Findings reveal a growing public health crisis with unsustainable health care costs NEW YORK, May 15, 2024 /PRNewswire/ --  Key takeaways The projected cumulative cost of mental health inequities is estimated to amount to $14 trillion by the year 2040.The U.S. currently spends an estimated $477.5 billion annually in avoidable and unnecessary expenses relat...

Mental Health Inequities Cost the US More Than $477 Billion Today and Could Increase to $14 Trillion by 2040 if Unaddressed, According to Analysis by Deloitte and Meharry School of Global Health
Mindpath Health releases Finding Your Path to Mental Wellness

Caring for your mental health is a journey and there isn't just one right path. There are many avenues to mental well-being that can complement your individual situation. May is Mental Health Awareness Month-a great...

Mindpath Health releases Finding Your Path to Mental Wellness
AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain

TORONTO, May 15, 2024 /PRNewswire/ - AmacaThera Inc, a clinical stage biotechnology company specializing in the development of advanced sustained release hydrogel formulations, has dosed its first human subject with...

AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain
HUNDREDS OF PHYSICIANS AND MEDICAL PRACTITIONERS SET TO CONVENE AT THE 2024 ANNUAL CIRS CONFERENCE TO ADDRESS MOLD ILLNESS, WHICH AFFECTS MILLIONS OF AMERICANS

Dr. Scott McMahon of Whole World Health Care is happy to announce the 2024 annual Surviving Mold-CIRSx Conference, set to be held May 16-19, 2024 at the Hyatt Regency, located at 2615 Preston Road in Frisco, Texas, a city...

HUNDREDS OF PHYSICIANS AND MEDICAL PRACTITIONERS SET TO CONVENE AT THE 2024 ANNUAL CIRS CONFERENCE TO ADDRESS MOLD ILLNESS, WHICH AFFECTS MILLIONS OF AMERICANS
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that Eisai has...

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
The National Kidney Foundation's 2024 Spring Clinical Meetings Late-Breaking Presentation on New Therapy Shows Promising Results for IgAN Patients

During a late-breaking abstract presentation at the annual 2024 NKF Spring Clinical Meetings (SCM) tomorrow Dr. Dana Rizk, from the University of Alabama at Birmingham (UAB) Medical Center, will present data on the impact...

The National Kidney Foundation's 2024 Spring Clinical Meetings Late-Breaking Presentation on New Therapy Shows Promising Results for IgAN Patients
Meditrina Announces CE Mark Approval and First Multi-International Cases Performed

Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation (EU) 20147/745, for its state-of-the-art Aveta Hysteroscopy...

Meditrina Announces CE Mark Approval and First Multi-International Cases Performed
New CHOP Research Links Genetics, Environment and Health Disparities to Increased Stress and Mental Health Challenges During Adolescence

A new study from researchers at Children's Hospital of Philadelphia (CHOP) reveals that the cumulative "wear and tear" on the body known as allostatic load (AL) can be measured in early adolescence and that childhood...

New CHOP Research Links Genetics, Environment and Health Disparities to Increased Stress and Mental Health Challenges During Adolescence
Asembia introduces their latest technology suite to enhance patient speed to therapy, prescriber engagement and a new field team platform for manufacturers

Asembia has introduced a new technology solution designed to improve their services for patients enrolled in ASPN HUB Support Programs. By utilizing their advanced Asembia-1 platform, along with automation and AI, this...

Asembia introduces their latest technology suite to enhance patient speed to therapy, prescriber engagement and a new field team platform for manufacturers
ICAN Act Increases Patient Access to High-Quality Healthcare Throughout the United States

During a congressional briefing today, leaders from American Association of Nurse Anesthesiology (AANA), along with associations representing other advanced practice registered nurses (APRNs), outlined how current Centers...

ICAN Act Increases Patient Access to High-Quality Healthcare Throughout the United States
SprintRay Introduces Pro 2 3D Printer with Array of New Features

SprintRay, the market leader in dental 3D printing, revealed the latest in their line of desktop 3D printers, Pro 2, along with two new resins from the Company's BioMaterial Innovation Lab - a direct-print Retainer,...

SprintRay Introduces Pro 2 3D Printer with Array of New Features
Ember Cube Named Winner of Fast Company's 2024 World Changing Ideas Awards

Ember LifeSciences, Inc. today announced that its innovative cloud-based shipping box, the Ember Cube, has been recognized as the winner of the Health Products category of Fast Company's 2024 World Changing Ideas Awards.

Ember Cube Named Winner of Fast Company's 2024 World Changing Ideas Awards
Bond Named a Platinum Best Managed Company for Seventh Consecutive Year

TORONTO, May 14, 2024 /PRNewswire/ - Bond was recognized for its industry-leading performance, its global business practices, and its sustained growth by receiving the prestigious 2024 Best Managed Companies award.

Bond Named a Platinum Best Managed Company for Seventh Consecutive Year
Apotex Corp. Launches Generic Fertility Treatment Injectable Cetrorelix® in the United States

WESTON, Fla., May 14, 2024 /PRNewswire/ - Apotex Corp. announced today the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.

Apotex Corp. Launches Generic Fertility Treatment Injectable Cetrorelix® in the United States
Blue Zones and American College of Lifestyle Medicine Create Partnership to Accelerate a Lifestyle-First Approach to All Healthcare

Blue Zones and the American College of Lifestyle Medicine (ACLM) have announced a global impact partnership to address the health crisis of rising chronic disease rates and rising healthcare-related costs. Blue Zones, the...

Blue Zones and American College of Lifestyle Medicine Create Partnership to Accelerate a Lifestyle-First Approach to All Healthcare
DOAR Releases Results from a National Survey of Jurors' Attitudes Toward Pharmaceutical Companies

DOAR, the nation's leading trial consulting company, today released important findings from a new national study that examines several issues suspected of influencing jurors' baseline attitudes toward...

DOAR Releases Results from a National Survey of Jurors' Attitudes Toward Pharmaceutical Companies
UPSHER-SMITH NAMED AS 2024 ASAP ALLIANCE EXCELLENCE AWARD FINALIST

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has been named by The Association of Strategic Alliance Professionals (ASAP) as an ASAP Alliance Excellence Award finalist in two categories. ASAP...

UPSHER-SMITH NAMED AS 2024 ASAP ALLIANCE EXCELLENCE AWARD FINALIST
CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, today announced its participation at the Heart Rhythm 2024 conference, taking place in person at the Boston...

CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024
Healthcare Pioneers Medically Home Group and Siemens Healthineers Forge a Collaboration to Enhance Capabilities for Providing Advanced Patient Care at Home

Medically Home Group, the leading company in developing and operationalizing decentralized care to the home for patients with serious, complex, or high-risk illness, together with Siemens Healthineers, a leading...

Healthcare Pioneers Medically Home Group and Siemens Healthineers Forge a Collaboration to Enhance Capabilities for Providing Advanced Patient Care at Home
NOVEL OMEZA® OCM™ WOUND MATRIX DEMONSTRATES MULTI-MODAL EFFECTS BY REDUCING BACTERIAL CONTAMINATION IN "STALLED", HARD TO TREAT WOUNDS, WHILE SUPPORTING HEALING RATES

Omeza®, a regenerative skincare company that develops marine-based therapies for wounds that are hard to treat, today announced a submission of an evaluation of OCM™ Wound Matrix to a wound care journal under the peer...

NOVEL OMEZA® OCM™ WOUND MATRIX DEMONSTRATES MULTI-MODAL EFFECTS BY REDUCING BACTERIAL CONTAMINATION IN "STALLED", HARD TO TREAT WOUNDS, WHILE SUPPORTING HEALING RATES
Springbok's Full Body MRI Muscle Health Analysis Named to Fast Company's 2024 World Changing Ideas Awards

An honorable mention in the Health Services category, Springbok Analytics is building the new standard in muscle health

Springbok's Full Body MRI Muscle Health Analysis Named to Fast Company's 2024 World Changing Ideas Awards
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain

Brixton Biosciences, a spin-out from Massachusetts General Brigham and a clinical stage life sciences company developing novel therapies for chronic and acute pain, today announced that it closed a Series B funding round...

Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
OrthAlign Launches Lantern® Handheld Technology for Total, Partial, and Revision Knee Arthroplasty in Japan.

OrthAlign, Inc., a leading innovator in surgical technology, announces the launch of its flagship product, Lantern, in Japan. The launch will be driven by its longstanding commercial partner, who have represented OrthAlign...

OrthAlign Launches Lantern® Handheld Technology for Total, Partial, and Revision Knee Arthroplasty in Japan.
Introducing Triune™ Rx Medicated Eyelid Treatment

OCuSOFT Inc., member company of the Southwest Research & Technology Center (SWRTC) housed on its campus grounds, is pleased to announce the licensing of its patented OCuSOFT® Lid Scrub® PLUS formulation to Primera...

Introducing Triune™ Rx Medicated Eyelid Treatment
Comprehensive Provider Survey Confirms HealthTrackRx Next-Morning Results Impacted Antibiotic Prescribing 80% of the Time

HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, releases the findings of a recent survey to understand better how next-morning PCR results reduce unnecessary prescribing for infection...

Comprehensive Provider Survey Confirms HealthTrackRx Next-Morning Results Impacted Antibiotic Prescribing 80% of the Time
Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Diurnal Ltd., a Neurocrine Biosciences company, presented baseline data from the CAHtalyst™ Phase 3 studies of crinecerfont in adult and pediatric patients with congenital...

Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer's Disease at Discovery Europe 2024

Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the unveiling of a new clinical program evaluating its...

Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer's Disease at Discovery Europe 2024
Children's Hospital of Philadelphia Announces Name of New Research Hub: The Morgan Center for Research and Innovation

Children's Hospital of Philadelphia (CHOP) today announced that it has received a significant philanthropic gift from Mitchell L. Morgan, Dr. Hilarie L. Morgan and their family to name its state-of-the-art research...

Children's Hospital of Philadelphia Announces Name of New Research Hub: The Morgan Center for Research and Innovation
Big Blue Marble Academy Students Raise Funds to Provide Essential Pre- and Postnatal Care, Food and Water for Mothers in Africa

Big Blue Marble Academy (BBMA), a leader in early childhood education, today announced the culmination of a national fundraising effort to collect "Change for Change" to provide pre-and postnatal care for 140 mothers and...

Big Blue Marble Academy Students Raise Funds to Provide Essential Pre- and Postnatal Care, Food and Water for Mothers in Africa
Precision for Medicine Opens Expanded State-of-the-Art Biomarker Research and Companion Diagnostic Laboratory in Frederick, Maryland

Precision for Medicine, a global leader in biomarker-driven clinical research and development supporting life sciences companies, today announced the completion of a major expansion to its laboratory campus in Frederick,...

Precision for Medicine Opens Expanded State-of-the-Art Biomarker Research and Companion Diagnostic Laboratory in Frederick, Maryland
CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for...

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
Two Constitution Surgery Alliance Facilities are Named in U.S. News & World Report's Inaugural "Best Ambulatory Surgery Centers" Edition

East Bay Surgery Center ("East Bay") and Middlesex Endoscopy Center ("Middlesex") have been recognized by U.S. News & World Report among the 2024-2025 Best Ambulatory Surgery Centers. Both East Bay and Middlesex are...

Two Constitution Surgery Alliance Facilities are Named in U.S. News & World Report's Inaugural "Best Ambulatory Surgery Centers" Edition